Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Acadia

Acadia Emerges From Behind The Scenes With A Potential $12 Billion Opportunity

Acadia Pharmaceuticals is working on its next-generation Nuplazid and, for CEO Catherine Owen Adams, the journey is personal.

Investors Business Daily

“I used different gadgets to make the guitar sound different. I used a few hammers – I don’t recommend that”: How Yasmin Williams is redefining the people’s music with kitchen implements and acoustic guitar

“I used different gadgets to make the guitar sound different. I used a few hammers – I don’t recommend that”: How Yasmin Williams is redefining the people’s music with kitchen implements and acoustic guitar

The acoustic folk virtuoso even used a frother from her parents’ kitchen to get a tone on new album Acadia, but, she tells us, the end justifies the means

3 Hidden Bargains in the Healthcare Sector

3 Hidden Bargains in the Healthcare Sector

Healthcare’s resilience makes it a go-to sector during market volatility. With steady demand, innovation, and aging demographics driving growth, investors could consider investing in fundamentally sound stocks like Viatris (VTRS), Bausch + Lomb Corp. (BLCO), and ACADIA Pharmaceuticals (ACAD). With strong industry tailwinds and discounted valuations, these stocks could offer…

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Yasmin Williams, folk’s fantastical fingerpicker: ‘Guitar Hero shaped my experimental approach’

After shredding on a video game axe during her teens, the American musician graduated to the real thing. She explains how her music chooses hope during dark times

The Guardian - UK

Biotech Stocks: Why Acadia Pharma And Others Are Feeling 'Growing Pains'

Acadia Pharmaceuticals led a biotech stock sell-off Wednesday after revenue from its Rett syndrome treatment missed expectations.

Investors Business Daily

3 Pharma Stocks to Buy for Potential Financial Fortunes

Amid surging medicine demand and ongoing drug shortages, the pharmaceutical industry thrives, driving improved patient outcomes and promising growth opportunities for investors. So, it could be wise to invest in quality pharma stocks ACADIA Pharmaceuticals (ACAD), Neurocrine Biosciences (NBIX), and Supernus Pharmaceuticals (SUPN), which can help you fetch potential financial…

Martha Stewart designed a 'versatile' outdoor furniture range inspired by the beauty of her 1925 Carriage House

The entertaining icon just brought 'timeless' class to hosting season – these are our favorite pieces from her collection

Homes & Gardens

inkl

Read news from The Economist, FT, and more,
with one subscription

Acadia Hits 11-Month Low After Outsized Placebo Effect Torpedoes Schizophrenia Study

Acadia Hits 11-Month Low After Outsized Placebo Effect Torpedoes Schizophrenia Study

Acadia stock crashed Tuesday after an outsized placebo effect torpedoed the company's efforts to expand Nuplazid to schizophrenia patients.

Investors Business Daily

Acadia Stock Dives As Unexpected Seasonality Rocks Its Most High-Profile Launch

Acadia stock plunged Wednesday after the company issued light guidance for Daybue. ACAD stock undercut its 50-day line.

Investors Business Daily

Acadia Soars To A Four-Month High After Winning A Patent Battle For Its Biggest Drug

Acadia Soars To A Four-Month High After Winning A Patent Battle For Its Biggest Drug

Acadia notched a win in a patent battle Wednesday pertaining to its Parkinson's drug and ACAD stock soared to a four-month high.

Investors Business Daily

2024 GMC Acadia Debuts: Bigger Bod With 328 HP, 15-Inch Portrait Display

2024 GMC Acadia Debuts: Bigger Bod With 328 HP, 15-Inch Portrait Display

It's nearly a foot longer with 80 percent more cargo space, and it's available with Super Cruise for hands-free driving.

Watch Rocket Lab launch Earth-observing radar satellite

Watch Rocket Lab launch Earth-observing radar satellite

Rocket Lab plans to launch an Earth-observing radar satellite for the company Capella Space in the coming days, and you can watch the action live.

Acadia's Newest Drug Just Obliterated Sales Expectations; Shares Hit Two-Year High

Acadia's Newest Drug Just Obliterated Sales Expectations; Shares Hit Two-Year High

Acadia obliterated expectations for the launch quarter of its Rett syndrome treatment and, on Friday, ACAD stock hit a two-year high.

Investors Business Daily

Biotech Daily: Thumbs Down For Acadia's Antipsychotic Drug, Akebia Fails COVID-19 Study, Kazia's Encouraging Data In Brain Metastases

Biotech Daily: Thumbs Down For Acadia's Antipsychotic Drug, Akebia Fails COVID-19 Study, Kazia's Encouraging Data In Brain Metastases

Here's a roundup of top developments in the biotech space over the last 24 hours:

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga Before The Bell: Should Investors Worry About Tesla's China Sales, Gold Back In Focus, Nio Smartphone Could Soon Be A Reality Other Top Financial Stories Friday, August 5

CNBC International Airlines Prepare For Mayhem Of Summer Travel Season: Report

The Daily Biotech Pulse: FDA Tentatively Approves Avadel's Narcolepsy Drug, European Approval Broadens AstraZeneca's Enhertu in Breast Cancer, Pharma Giants' Earnings

Here's a roundup of top developments in the biotech space over the last 24 hours:

Analysts Try To See Beyond Acadia's Alzheimer's Disease Psychosis

HC Wainwright says that a negative AdCom vote on Acadia Pharmaceuticals Inc&#

Investors Business Daily

Acadia Pharmaceuticals Crashes After FDA Panel Votes Down Its Alzheimer's Psychosis Drug

FDA experts voted against Acadia Pharmaceuticals' Alzheimer's disease psychosis drug, leading ACAD stock to plummet.

Get all your
news in one place.

100’s of premium titles.
One news app.

The Daily Biotech Pulse: Thumbs Down For Acadia's Pimavanserin, Pfizer Buys Stake In Valneva, AstraZeneca - Ionis Eplontersen Aces Rare Disease Trial

Here's a roundup of top developments in the biotech space over the last 24 hours:

HC Wainwright Sees Opportunity For Acadia's Alzheimer's Candidate

HC Wainwright says FDA's briefing document on ACADIA Pharmaceuticals Inc's (NASDAQ: ACAD) pimavanserin was not unexpected.

Why ACADIA Pharmaceuticals Shares Are Trading Higher Today?

Ahead of Acadia Pharmaceuticals Inc's (NASDAQ:ACAD) FDA AdComm meeting on Friday, the agency officials released their briefing documents, revealing a mixed bag of opinions. The company's resubmitted supplemental New Drug Application for pimavanserin for hallucinations and delusions associated with Alzheimer's disease psychosis (ADP) has a target action date of August 4. Initially, the FDA…

Investors Business Daily

Why Acadia Pharma Surged Despite A Negative FDA Take On Its Lead Drug

There were no surprises in the FDA's assessment of an Alzheimer's drug from Acadia Pharmaceuticals, and ACAD stock surged Wednesday.

Investors Business Daily

IBD Stock Of The Day: Health Care Provider Acadia Posting Healthy Growth Outlook

Acadia Healthcare stock is the IBD Stock Of The Day, as the country's leading behavioral services provider looks to build on its strong first-quarter earnings.

The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs

Here's a roundup of top developments in the biotech space over the last 24 hours.

Why Acadia Pharma Shares Are Falling Today

Acadia Pharmaceuticals Inc (NASDAQ: ACAD) announced topline results from a Phase 2 trial evaluating the efficacy and safety of ACP-044 for acute pain following bunionectomy surgery.

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

European Commission

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Alzheimer Disease

Places

290,176 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play